|
International Medicine and Infectious Disease
A Phase II Dose-Escalating, Placebo-Controlled, Double-Blind, Parallel Group Study in HIV Treatment-Experienced Patients to
Evaluate the Safety ...
Investigator: Gulick, Roy M
Phone Number: x6-4177
Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211
Investigator: Gulick, Roy M
Phone Number: x6-4177
HVTN: HIV Vaccine Clinical Trials Unit
Investigator: Pape, Jean W.
Phone Number: 746-6320
Port-au-Prince, Haiti HIV Vaccine Trials Unit - HVTN 502 Funds
Investigator: Pape, Jean W.
Phone Number: 746-6320
Port-au-Prince, Haiti HIV Vaccine Trials Unit- HVTN 050 Funds
Investigator: Pape, Jean W.
Phone Number: 746-6320
Open lable Study to ... Efficacy and Safety of Daptomycin in Combination with Anti-cell Wall Active Therapy ... Treatment
of Enterococcal Endocarditis
Investigator: Rhee, Kyu Y.
Phone Number: 746-6320
Phase II randomized, controlled, partially blinded,48wk trial to investigate dose response of TMC114/RTV in 3 class experienced,
multi-PI-experienced
Investigator: Wilkin, Timothy
Phone Number: x6-4177
A Phase II Open-label 48 Week Trial of TMC114/RTV in HIV-1 Infected Subjects Who Failed Trial Treatment in the Control Group
of Sponsor Selected Trial
Investigator: Wilkin, Timothy
Phone Number: x6-4177
An Open-Label, Pilot Trial of Diindolylmethane (Bioresponse DIM) for the Treatment of Anal Human Papilomavirus Infection
Investigator: Wilkin, Timothy
Phone Number: x6-4177
an open-label trial with TMC125 as part of an ART including TMC114/rtv and an Investigator selected IBR in HIV-1 infected
subjects who participated in
Investigator: Wilkin, Timothy
Phone Number: x6-4177
|
